Authors


Nirupama (Rupa) Pike, PhD

Latest:

From Early Development to Commercialization: Strategies for Successful Cell Therapy Manufacturing

Dr Rupa Pike, Sr. Director & Global Head Strategic Alliances and Field Scientists for Cell Therapy, Catalent, shares insight on de-risking cell therapy programs using streamlined development and manufacturing platforms.


Stephen Shapka

Latest:

Contamination Control for Cell and Gene Therapies Needs New Analytics

Analytical methods need a boost to ensure quality control for cell and gene therapies.


Dharmang Pandya

Latest:

Formulation of Modified Liquid-Solid Compact for Dissolution Enhancement of Raloxifene Hydrochloride

The purpose of this research was to formulate modified liquisolid compacts (MLSC) of RLX for improved dissolution in immediate-release tablet formulations.


David McErlane

Latest:

The Evolution of Cell & Gene Therapy: Development and Manufacturing Insights and the Role of CDMOs

David McErlane, Group President of Biologics, Catalent, reacts to trends in cell and gene therapy development and manufacturing and comments on Catalent's ESG strategy to support people, the environment, and communities.


Revvity

Latest:

Harnessing cell line engineering capabilities to enhance biotherapeutic products

Explore the potential of next-generation genome editing tools for driving the success of monoclonal antibodies for biotherapeutics.


Barbara Rellahan

Latest:

Overcoming Challenges to Biopharmaceutical Development and Manufacture with Science- and Risk-Based Strategies

Many biologic drug manufacturers encounter similiar challenges; precompetitive collaboration can help resolve these issues. Representatives of the IQ Consortium’s Biologics CMC Leadership Group describe efforts to address the safe handling of biologic drugs in closed-system transfer devices in healthcare settings and the need for phase-appropriate specifications.


Torkel Gren

Latest:

Modified Release: A Pathway to More Patient-Friendly Medication

Modified-release dosage forms present new opportunities for drug developers and can help overcome challenges, such as short biological half-life or poor bioavailability due to degradation in the stomach.


M.A. Repka

Latest:

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.


Raphael Bar

Latest:

Determination of Shelf-Life from Stability Data: From Replicates or from Averages?

A statistical analysis for determining an expiration date can be applied to replicates or their corresponding averages as suggested in industry guidelines.


Ramesh Ramani

Latest:

Beyond GenAI: The Training-Free Discovery Potential of LLMs in a Drug Safety and Regulatory Context

Life sciences data sets can be vast and complex to process, but up to now bringing intelligent automation systems up to speed and validating them has felt debilitatingly onerous. Large language models tackle these barriers head on. Ramesh Ramani and RaviKanth Valigari, technology innovators at ArisGlobal, explain.


Matt Bauer

Latest:

Converging InformationTechnology & Automation Teams

Getting IT, engineering, and manufacturing on the same page requires a delicate balance.


Sergio Alcalá-Alcalá

Latest:

Thermogelling Matrix-Containing Platelet Lysate-Loaded Elastic Liposomes as a Potential Treatment of Wounds

The purpose of this article was to demonstrate the application of a new thermogelling matrix in the healing of wounds.


Reinhard Vollmer

Latest:

An All-Round Excipient For Direct Compression

Using new co-processing technologies, the authors show that it is possible to formulate an 'all-round' excipient.


Shriya Bhatkhande

Latest:

Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023

More than a third of CMOs are struggling to keep skilled technical and production staff.


Nasser N. Nyamweya

Latest:

Chewable Tablets: A Review of Formulation Considerations

This paper reviews considerations for the formulation of chewable tablets including sensory characteristics, chewability assessment, and drug release.



Carl Levoguer 

Latest:

Characterizing A Nasal Spray Formulation From Droplet To API Particle Size

The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.


Bernard Sagaert

Latest:

Delivering on the Potential of mRNA Therapeutics

The complexity of the RNA production process creates challenges.


Patty Cheung

Latest:

Effective and Efficient Weighing of Potent Compounds

The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.


Michael Moedler

Latest:

Accelerating Workforce Training on Single-Use Technologies

Training is crucial for supporting GMP operations in commercial-scale bioprocessing.


Jae Han Park, PhD

Latest:

An Alternative to the USP Disintegration Test for Orally Disintegrating Tablets

The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.


Nemera Services

Latest:

Patient Journey as a key to develop Inhalation combination products v3

Discover why integrating Human Factors and patient activities from early device to manufacturing is essential to develop a patient-centric inhaler.


Kevin M. Holman

Latest:

An Alternative to the USP Disintegration Test for Orally Disintegrating Tablets

The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.


S. Narasimha Murthy

Latest:

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.


Cheryl Barton

Latest:

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.


Patrick Lavery

Latest:

Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan

The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.


Oliver Luhn

Latest:

Using Excipients In Powder Formulations

During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market.


Ammar Khawam

Latest:

Process Performance as a Means of Quality Management

Process performance metrics of eight different mechanical devices were assessed to evaluate compliance with regulatory and compendial criteria.



Harbinder Pordal

Latest:

Harnessing Predictive Simulation to Improve Mixing

Predictive computational methods are finding wider use in pharmaceutical solid dosage development, particularly in mixing and blending, to improve tech transfer and equipment selection, and speed the acquisition of process understanding.